Related Experiment Video
Updated: Jul 17, 2026

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses
Published on: May 5, 2014
Computational models of antiviral toxicity
1Virginia Polytechnic Institute and State University, Virginia Bioinformatics Institute, Washington Street, MC 0477, Blacksburg, VA 24061, USA. DSamuels@vbi.vt.edu
Computational models can help predict antiviral drug toxicity, a common issue in treating chronic viral infections like HIV. This review examines studies using computational and experimental methods to understand and mitigate drug side effects.
Area of Science:
- Pharmacology
- Computational Biology
- Toxicology
Background:
- Antiviral drug toxicity is a significant challenge in managing chronic viral infections.
- Long-term treatment, particularly for HIV, often leads to adverse drug reactions.
Purpose of the Study:
- To review the application of computational models in understanding antiviral drug toxicity.
- To analyze recent research combining experimental and computational approaches to antiviral toxicity.
Main Methods:
- Literature review of studies employing computational and experimental techniques.
- Analysis of different perspectives on antiviral toxicity explored in recent research.
Main Results:
- Computational models offer a valuable approach to exploring antiviral drug toxicity.
- Integration of experimental and computational methods provides diverse insights into drug side effects.
Conclusions:
- Computational modeling shows promise in addressing antiviral drug toxicity.
- Future research should focus on refining these models and exploring new avenues for mitigating drug-induced adverse effects.
Related Concept Videos
Antiviral Nucleoside Inhibitors
Pharmacodynamic Models: Additive and Proportional Drug Effect Model
Pharmacodynamic Models: Direct Effect Model and Indirect Response Model
Pharmacodynamic Models: Overview
Pharmacodynamic Models: Emax Drug–Concentration Effect Model
Inhibitors of Viral Protein Synthesis

